Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00328185 · ClinicalTrials.gov registry record
Allograft Fibrosis Following Pediatric Cardiac Transplantation
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Terminated
- Registry status
- 100
- Enrollment target
NCT00328185 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 100 participants.
The verdict
NCT00328185 was terminated before completion, sponsored by Children's Healthcare of Atlanta.
- TERMINATED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Transplantation is the preferred method of treating many forms of end-stage organ failure. While short-term results have improved, long-term outcomes remain inadequate. Myocardial fibrosis could potentially have an adverse effect on long-term cardiac function. We wish to study the degree of fibrosis to see if we can predict survival following pediatric heart transplantation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2006-01 |
| Est. Completion | 2006-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00328185
The ClinicalTrials.gov registry entry for NCT00328185 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Healthcare of Atlanta, which has 80 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00328185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00328185 about?
NCT00328185 is a clinical study titled "Allograft Fibrosis Following Pediatric Cardiac Transplantation". Transplantation is the preferred method of treating many forms of end-stage organ failure. While short-term results have improved, long-term outcomes remain inadequate. Myocardial fibrosis could potentially have an adverse effect on long-term cardiac function. We wish to study the degree of fibrosis...
What is the current status of trial NCT00328185?
This trial is currently terminated. The enrollment target is 100 participants. The study started on 2006-01. Estimated completion is 2006-12.
Who is sponsoring clinical trial NCT00328185?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.